Editas Medicine (EDIT) Assets (2015 - 2025)

Editas Medicine (EDIT) has 11 years of Assets data on file, last reported at $186.5 million in Q4 2025.

• Assets for Q4 2025 came in at $186.5 million, down 45.39% year-over-year; the trailing twelve-month figure through Dec 2025 was $186.5 million (down 45.39% YoY), and the FY2025 annual result was $186.5 million, down 45.39% from the prior year.
• Assets eased to $186.5 million in Q4 2025 per EDIT's latest filing, from $201.8 million in the prior quarter.
• Over five years, Assets peaked at $780.3 million in Q1 2021 and troughed at $186.5 million in Q4 2025.
• A 5-year average of $477.3 million and a median of $501.9 million in 2023 frame the typical range for Assets.
• The sharpest annual moves came in 2021 and 2025: Assets surged 67.18% in 2021, then tumbled 45.39% in 2025.
• A 5-year view of Assets shows it stood at $677.5 million in 2021, then fell by 24.08% to $514.3 million in 2022, then dropped by 2.95% to $499.2 million in 2023, then plunged by 31.57% to $341.6 million in 2024, then plunged by 45.39% to $186.5 million in 2025.
• Business Quant data shows EDIT's Assets at $186.5 million in Q4 2025, $201.8 million in Q3 2025, and $210.6 million in Q2 2025.